Development and validation of a prognostic score during tuberculosis treatment

被引:20
|
作者
Pefura-Yone, Eric Walter [1 ,2 ]
Balkissou, Adamou Dodo [1 ,2 ]
Poka-Mayap, Virginie [1 ]
Fatime-Abaicho, Hadja Kote [3 ]
Enono-Edende, Patrick Thierry [3 ]
Kengne, Andre Pascal [4 ,5 ]
机构
[1] Univ Yaounde I, Fac Med & Biomed Sci, Dept Internal Med & Special, Yaounde, Cameroon
[2] Yaounde Jamot Hosp, POB 4021, Yaounde, Cameroon
[3] Inst Super Technol Med, Yaounde, Cameroon
[4] MRC, Cape Town, South Africa
[5] Univ Cape Town, Cape Town, South Africa
关键词
Tuberculosis; Mortality; Prediction; Risk score; IMMUNODEFICIENCY-VIRUS-INFECTION; RISK-FACTORS; PULMONARY TUBERCULOSIS; TREATMENT OUTCOMES; MORTALITY; DEATH; ADULTS; PREDICTION; COHORT; INPATIENTS;
D O I
10.1186/s12879-017-2309-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Death under care is a major challenge for tuberculosis (TB) treatment programs. We derived and validated a simple score to predict mortality during tuberculosis treatment in high endemicity areas. Methods: We used data for patients aged >= 15 years, diagnosed and treated for tuberculosis at the Yaounde Jamot Hospital between January 2012 and December 2013. Baseline characteristics associated with mortality were investigated using logistic regressions. A simple prognosis score (CABI) was constructed with regression coefficients for predictors in the final model. Internal validation used bootstrap resampling procedures. Models discrimination was assessed using c-statistics and calibration assessed via calibration plots and the Hosmer and Lemeshwow (H-L) statistics. The optimal score was based on the Youden's index. Results: A total of 2250 patients (men 57.2%) with a mean age of 35.8 years were included; among whom 213 deaths (cumulative incidence 9.5%) were recorded. Clinical form of tuberculosis (C), age (A, years), adjusted body mass index (B, BMI, kg/m(2)) and status for HIV (Human immunodefiency virus) infection (I) were significant predictors in the final model (p < 0.0001) which was of the form Death risk = 1/(1 + e(-(-1.3120 + 0.0474) * (age -0.1866) * (BMI + 1.1637) ((if smear negative TB) +) (0.5418(if extra -pulmonary TB) + 1.3820(if HIV+)))). The c-statistic was 0.812 in the derivation sample and 0.808 after correction for optimism. The calibration was good [H-L chi(2)= 6.44 (p = 0.60)]. The optimal absolute risk threshold was 4.8%, corresponding to a sensitivity of 81% and specificity of 67%. Conclusions: The preliminary promising findings from this study require confirmation through independent external validation studies. If confirmed, the model derived could facilitate the stratification of TB patients for mortality risk and implementation of additional monitoring and management measures in vulnerable patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Development and validation of a prognostic score during tuberculosis treatment
    Eric Walter Pefura-Yone
    Adamou Dodo Balkissou
    Virginie Poka-Mayap
    Hadja Koté Fatime-Abaicho
    Patrick Thierry Enono-Edende
    André Pascal Kengne
    BMC Infectious Diseases, 17
  • [2] Development and validation of a prognostic score to predict tuberculosis mortality
    Nguyen, Duc T.
    Graviss, Edward A.
    JOURNAL OF INFECTION, 2018, 77 (04) : 283 - 290
  • [3] Development and validation of a tuberculosis prognostic score for smear-positive in-patients in Japan
    Horita, N.
    Miyazawa, N.
    Yoshiyama, T.
    Sato, T.
    Yamamoto, M.
    Tomaru, K.
    Masuda, M.
    Tashiro, K.
    Sasaki, M.
    Morita, S.
    Kaneko, T.
    Ishigatsubo, Y.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (01) : 54 - 60
  • [4] Development and Validation of a Prognostic Score for Intrahepatic Cholangiocarcinoma
    Raoof, Mustafa
    Dumitra, Sinziana
    Ituarte, Philip H. G.
    Melstrom, Laleh
    Warner, Susanne G.
    Fong, Yuman
    Singh, Gagandeep
    JAMA SURGERY, 2017, 152 (05) : e170117
  • [5] Caustic ingestion: development and validation of a prognostic score
    Tosca, Joan
    Villagrasa, Rosana
    Sanahuja, Ana
    Sanchez, Ana
    Trejo, Galo Antonio
    Herreros, Belen
    Pascual, Isabel
    Mas, Pilar
    Pena, Andres
    Minguez, Miguel
    ENDOSCOPY, 2021, 53 (08) : 784 - 791
  • [6] Development and Validation of a Simplified Prognostic Score in SCLC
    Negre, Elodie
    Coffy, Amandine
    Langlais, Alexandra
    Daures, Jean-Pierre
    Lavole, Armelle
    Quoix, Elisabeth
    Molinier, Olivier
    Greillier, Laurent
    Audigier-Valette, Clarisse
    Moro-Sibilot, Denis
    Westeel, Virginie
    Morin, Franck
    Roch, Benoit
    Pujol, Jean-Louis
    JTO CLINICAL AND RESEARCH REPORTS, 2020, 1 (01):
  • [7] CAUSTIC INGESTION: DEVELOPMENT AND VALIDATION OF A PROGNOSTIC SCORE
    Tosca, Joan
    Villagrasa, Rosana
    Sanahuja, Ana
    Trejo, Galo A.
    Herreros, Belen
    Aldea, Andres Pena
    Minguez, Miguel
    Mora, Francisco
    GASTROENTEROLOGY, 2017, 152 (05) : S891 - S891
  • [8] Development and Validation of the Tuberculosis Risk Score for Smokers (TBRSS)
    Tengku Khalid, Tengku Noor Farhana
    Wan Mohammad, Wan Mohd Zahiruddin
    Nik Husain, Nik Rosmawati
    Ab Samat, Razan
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (12)
  • [9] Reader variability and validation of the Timika X-ray score during treatment of pulmonary tuberculosis
    Thiel, B. A.
    Bark, C. M.
    Nakibali, J. G.
    van der Kuyp, F.
    Johnson, J. L.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (10) : 1358 - 1363
  • [10] DEVELOPMENT AND VALIDATION OF CLINICAL PREDICTION SCORE OF MORTALITY IN TUBERCULOSIS PATIENTS
    Saisudjarit, P.
    Saokaew, S.
    Duangjai, A.
    Prasatkhetrugarn, A.
    Kunchanasorakit, S.
    Phisalprapa, P.
    VALUE IN HEALTH, 2022, 25 (12) : S191 - S191